Elexacaftor Also Works as CFTR Potentiator, Study Says

Elexacaftor (VX-445), a next-generation CFTR࣯rrectorനat is part of the triple-combination therapy Trikafta, is also a potentiator, a study reports. Results further showed that in combination with ivacaftor, sold as Kalydeco and also a potentiator, elexacaftor boosts ion flow across CFTR, the channel protein that is defective in people with cystic fibrosis (CF) These findings support [ŝThe post Elexacaftor Also Works as CFTR Potentiator, Study Says appeared first on Cystic Fibrosis News Today